3D Bioprinting Market Projected to Reach $6.21 Billion by 2030 Driven by Personalized Medicine and Organ Demand

July 12, 2026

The Business Research Company (via OpenPR) Unknown

Overview

This article provides an overview of a market research report published by The Business Research Company. The 3D bioprinting market is projected to expand to $6.21 billion by 2030, fueled by advancements in personalized medicine, increasing demand for organ transplantation, and supportive regulatory frameworks. Key market drivers include Eli Lilly’s acquisition of Organovo’s FXR program and Tethon 3D’s entry into the bioprinting market with its Bison Bio DLP printer. This market expansion underpins the growing potential of bioprinting for innovative applications in regenerative medicine and pharmaceutical research.

In Depth

This article summarizes a market research report published by The Business Research Company.

Report Overview

According to the latest report from The Business Research Company, the 3D bioprinting market is forecast to reach approximately $6.21 billion by 2030. This robust growth is primarily driven by the advancements in personalized medicine, the escalating demand for organ transplantation, and favorable regulatory support from various governments. The expansion reflects significant innovations in technology and broader applications for creating biological tissues and organ substitutes. Geographically, North America currently holds the largest market share, with the Asia-Pacific region anticipated to exhibit the most rapid growth. The technology holds immense potential in fields such as regenerative medicine, drug discovery, and personalized therapeutic approaches.

Key Findings

Market size projected for 2030: $6.21 billion
Primary growth drivers: Progress in personalized medicine, increased demand for organ transplantation, and regulatory backing
Significant corporate activities fueling market growth: Eli Lilly’s acquisition of Organovo’s FXR program and Tethon 3D’s market entry with the Bison Bio DLP printer
Key application areas: Regenerative medicine, pharmaceutical research, disease modeling, and tissue engineering

The report provides a detailed analysis of key market segments, regional trends, the competitive landscape, and future opportunities. It particularly emphasizes the critical role of 3D bioprinting in constructing tissue and organ models, facilitating drug screening, and developing transplantable engineered products for therapeutic use.

About the Publisher

The Business Research Company is a global market research firm that offers in-depth market intelligence reports, business research, and consulting services. The company possesses extensive expertise across a wide range of industries, providing reliable data and analysis to assist businesses in making strategic decisions.

Source: https://www.openpr.com/news/4566976/3d-bioprinting-market-outlook-signals-expansion-to-6-21

Get our weekly technology intelligence — free

Receive an infographic that lets you judge at a glance whether each field’s analysis report is worth reading.

Subscribe Free — Weekly Tech Intelligence

By subscribing, you’ll receive Troy-Technical’s weekly technology intelligence newsletter.